Oral administration of calcitonin

Title: Oral administration of calcitonin

Related Patent Categories: Drug, Bio-affecting And Body Treating Compositions, Designated Organic Active Ingredient Containing (doai), Peptide Containing (e.g., Protein, Peptones, Fibrinogen, Etc.) Doai

Brief Patent Description - Full Patent Description - Patent Claims

The Patent Description & Claims data below is from USPTO Patent Application 20060135402, Oral administration of calcitonin.

1. A method of administration which comprises administering orally to a human host prior to the consumption of food a pharmaceutical composition comprising calcitonin in combination with one or more oral delivery agents.

2. A method according to claim 1, wherein oral administration is in the range of about 5 to 30 minutes prior to a meal.

3. A method according to claims 1, wherein said pharmaceutical composition comprises: a) an oral delivery agent being the disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid, N-(10-[2-hydroxybenzoyl]aminodecanoic acid or N-(8-[2-hydroxybenzoyl]amino)caprylic acid, or a hydrate or solvate of a said disodium salt; and b) about 0.1-2.5 mg of calcitonin; in which the ratio of the amount of the oral delivery agent, expressed as the corresponding amount of free acid, to the amount of calcitonin is in the range of about 10 to about 250:1 by weight.

4. (canceled)

5. (canceled)

6. (canceled)

7. An oral pharmaceutical composition comprising: a) an oral delivery agent being the disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid, N-(10-[2-hydroxybenzoyl]aminodecanoic acid or N-(8-[2-hydroxybenzoyl]amino)caprylic acid, or a hydrate or solvate of a said disodium salt; and b) about 0.1-2.5 mg of calcitonin; in which the ratio of the amount of the oral delivery agent, expressed as the corresponding amount of free acid, to the amount of calcitonin is in the range of about 10 to about 250:1 by weight.

8. An oral solid pharmaceutical composition according to claim 7, comprising N-(5-chlorosalicyloyl)-8-aminocaprylic acid disodium salt or a hydrate thereof and about 0.1-2.5 mg of salmon calcitonin, in which the ratio, as defined in said claim, of the amount of the oral delivery agent to the amount of calcitonin is in the range of about 10 to about 200:1 by weight.

9. An oral solid pharmaceutical composition according to claim 7, in which the ratio is about 25 to about 100:1 by weight.

10. An oral solid pharmaceutical composition according to claims 7, which also comprises either or both of crospovidone and povidone.

11. (canceled)

12. The kit according to claim 13, whereas in the calcitonin is salmon calcitonin and about 0.1-2.5 mg of salmon calcitonin; in which the ratio of the amount of the oral delivery agent, expressed as the corresponding amount of free acid, to the amount of salmon calcitonin is in the range of about 10 to about 250:1 by weight.

13. A kit comprising at least one pharmaceutical composition comprising calcitonin and an oral delivery agent, wherein said oral delivery agent is selected from the group consisting of the disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid, N-(10-[2-hydroxybenzoyl]aminodecanoic acid, N-(8-[2-hydroxybenzoyl]amino)caprylic acid, and hydrates or solvates of a said disodium salt, for administration to a human according to a method of oral administration which provides that said pharmaceutical composition may be taken prior to the consumption of food.

Brief Patent Description - Full Patent Description - Patent Claims

Click on the above for other options relating to this Oral administration of calcitonin patent application.
###

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.
Start now! - Receive info on patent apps like Oral administration of calcitonin or other areas of interest.
###

Previous Patent Application:
Novel method of selecting immunosuppressant having little thrombocytopenic effect
Next Patent Application:
Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
Industry Class:
Drug, bio-affecting and body treating compositions

###

Design/code © 2009 FreshContext LLC/Freshpatents.com. Website Terms and Conditions - Also read: About this Page
Patent data source: patents published by the United States Patent and Trademark Office (USPTO)
Information published here is for research/educational purposes only (and in conjunction with our Keyword Monitor) and is not meant to be used in place of the full USPTO patent document/images or a comprehensive patent archive search. Complete official applications are on file at the USPTO and often contain additional data/images (Freshpatents is currently text-only). FreshPatents.com is not affiliated with or endorsed by the USPTO or firms/individuals or products/designs/ideas related to listed patents.

FreshPatents.com Support
Thank you for viewing the Oral administration of calcitonin patent info.
IP-related news and info

Results in 0.07678 seconds

Other interesting Feshpatents.com categories:
Tyco , Unilever , Warner-lambert , 3m 174

* Protect your Inventions
* US Patent Office filing

Provisional Patent
Utility Patent

PATENT INFO